Clinical ThyroidologyVol. 32, No. 2 Greetings from the EditorFree AccessGreetings From the Editor of Clinical ThyroidologyAngela M. LeungAngela M. LeungSearch for more papers by this authorPublished Online:6 Feb 2020https://doi.org/10.1089/ct.2020;32.49-50AboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail DEAR COLLEAGUES,Welcome to another issue of Clinical Thyroidology. This month's issue contains a wide variety of important material, including the first of a new series of guest editorials that will be published throughout the year. We start this issue with a guest opinion/editorial on the topic of thyroid ultrasound certification in the United States by Dr. J. Woody Sistrunk, who has been a thought leader in this field alongside other experts and multiple key societies. It is a great look at the history of thyroid ultrasound use from the perspective of an endocrinologist, the evolution of certification for this procedure, and reimbursement considerations in the United States. As Woody outlines, it is also pertinent to mention that the American Thyroid Association (ATA) is planning what is sure to be a stimulating thyroid ultrasound course, specifically related to the active surveillance of biopsy-proven low-risk thyroid cancer, that will be held on May 28, 2020 (the first day of this year's ATA spring meeting), in New York City.We also present expert reviews on what we think are some of the most impactful and/or novel papers that have been published recently. On the topic of thyroid dysfunction, Dr. Daniel Toft reviews an interesting study examining the associations between major depressive disorder and thyroid surgery using a population-level database from South Korea. The controversial topic of cancer risk following radioactive iodine therapy for patients with hyperthyroidism is further examined in a study reviewed by Dr. Tim Korevaar. Drs. Marius Stan and George Kahaly then discuss a study regarding the role of prophylactic glucocorticoids for Graves’ orbitopathy in relation to the duration of Graves’ disease. As immunotherapy is being used more and more for the treatment of various malignancies, the endocrine-related adverse events will become increasingly pertinent to the practicing thyroidologist. Thus, Dr. Trevor Angell reviews an interesting study that shows a mortality benefit among patients in whom thyroiditis develops after the use of PD-L1 inhibitor therapy for nonthyroid cancers.Incidental thyroid nodules are a common part of an endocrine practice. Dr. Lisa Orloff discusses an intriguing study related to this, which reports that machine-assisted learning may outperform humans in predicting malignancy of a thyroid nodule. Dr. Benjamin Gigliotti is new to our editorial board and shares his first review on the implications of isolated extrathyroidal extension of papillary thyroid cancer into neck strap muscles. Finally, as the management of thyroid cancer continues to improve, it is important to consider the long-term quality of life and socioeconomic effects of this disease. Dr. Tracy Wang reviews a Canadian study examining quality of life-related measures among patients who undergo hemithyroidectomy, as compared with those who undergo a total thyroidectomy. Similarly, Dr. Maria Papaleontiou discusses a primarily U.S.-based study reporting quality-of-life outcomes and financial burden implications in patients with thyroid cancer.Finally, our monthly highlight of a first-author trainee case report presented at the 2019 American Thyroid Association Annual Meeting is by Dr. Aashka Shah and colleagues from Saint Michael's Medical Center in Newark, New Jersey, U.S.A. I invite everyone to read their interesting case report titled “A Choking ‘Wooden’ Goiter Resistant to Levothyroxine.”Our editorial team is proud to bring you these editorials, reviews, and case reports, and I hope that our material is directly helpful to your clinical thyroid practice. Thank you to our global friends and readers who are connecting with us through our social media channels. I invite you to come join these chats:Twitter:https://twitter.com/clinicalthyroid(@clinicalthyroid)Facebook:https://www.facebook.com/ThyroidAssociationLinkedIn:https://www.linkedin.com/company/american-thyroid-associationYoutube:https://www.youtube.com/user/thyroidorgOur reviews covered in Clinical Thyroidology are also translated into shorter lay summaries in our sister journal, Clinical Thyroidology for the Public (https://www.thyroid.org/patient-thyroid-information/ct-for-patients), that is edited by Dr. Alan Farwell and his team each month. The summaries in CTFP may be of use to patients and the public who have questions regarding recently published studies in the clinical thyroid literature.As always, thank you to both our new and faithful readers of Clinical Thyroidology. Please feel free to send me any questions or comments at clinicalthyroidology@thyroid.org.Warmest regards,Angela M. Leung, MD, MScEditor-in-Chief, Clinical ThyroidologyFiguresReferencesRelatedDetails Volume 32Issue 2Feb 2020 InformationCopyright 2020 American Thyroid Association, Inc.To cite this article:Angela M. Leung.Greetings From the Editor of Clinical Thyroidology.Clinical Thyroidology.Feb 2020.49-50.http://doi.org/10.1089/ct.2020;32.49-50Published in Volume: 32 Issue 2: February 6, 2020PDF download